Nika Pharmaceuticals, Inc (NIKA) Net Cash Flow (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Net Cash Flow came in at $20143.0 in Q3 2023, up 82.34% YoY from $11047.0 in Q3 2022, and down 80.12% on a QoQ basis from $101346.0 in Q2 2023.
Nika Pharmaceuticals, Inc (NIKA) Net Cash Flow (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Net Cash Flow data on file, last reported at $20143.0 in Q3 2023.
- Quarterly Net Cash Flow rose 82.34% year-over-year to $20143.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $125084.0 (up 84.23% YoY) and the FY2022 annual result came in at $67895.0, up 140.66% from the prior year.
- Net Cash Flow declined to $20143.0 in Q3 2023, from $101346.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $101346.0 in Q2 2023 to a low of -$959.0 in Q2 2021.
- A 3-year average of $20108.3 and a median of $11047.0 in 2022 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 3240.15% in 2022, down 24.41% in 2022.
- Tracing NIKA's Net Cash Flow over 3 years: stood at $28124.0 in 2021, then retreated by 3.82% to $27050.0 in 2022, then decreased by 25.53% to $20143.0 in 2023.
- The last three Net Cash Flow figures came in at $20143.0 (Q3 2023), $101346.0 (Q2 2023), and $3595.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 20,143.00 |
| Sep 30, 2023 | 20,143.00 |
| Jun 30, 2023 | 101,346.00 |
| Jun 30, 2023 | 101,346.00 |
| Mar 31, 2023 | 3,595.00 |
| Mar 31, 2023 | 3,595.00 |
| Dec 31, 2022 | 27,050.00 |
| Dec 31, 2022 | 27,050.00 |
| Sep 30, 2022 | 11,047.00 |
| Sep 30, 2022 | 11,047.00 |
| Jun 30, 2022 | 30,114.00 |
| Jun 30, 2022 | 30,114.00 |
| Mar 31, 2022 | -316.00 |
| Mar 31, 2022 | -316.00 |
| Dec 31, 2021 | 28,124.00 |
| Dec 31, 2021 | 28,124.00 |
| Sep 30, 2021 | 1,301.00 |
| Sep 30, 2021 | 1,301.00 |
| Jun 30, 2021 | -959.00 |
| Jun 30, 2021 | -959.00 |